Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenues, net	$ 95,306	$ 34,996
Operating expenses:
Cost of product sales	6,751	3,155
Selling, general and administrative	98,923	75,460
Research and development	38,024	29,043
Total operating expenses	143,698	107,658
Loss from operations	(48,392)	(72,662)
Interest income	4,349	548
Loss before provision for income taxes	(44,043)	(72,114)
Income tax expense	(10)	(5)
Net loss	$ (44,053)	$ (72,119)
Net loss per common share:
Basic (in dollars per share)	$ (0.46)	$ (0.78)
Diluted (in dollars per share)	$ (0.46)	$ (0.78)
Weighted average number of common shares:
Basic (in shares)	95,134,694	92,604,290
Diluted (in share)	95,134,694	92,604,290
Product sales, net
Total revenues, net	$ 94,731	$ 34,755
Grant revenue
Total revenues, net	$ 575	$ 241